Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Inflammation is the main determinant of bone loss in naive patients with Crohn disease (CROSBI ID 541088)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Turk, Nikša ; Čuković-Čavka, Silvija ; Koršić, Mirko ; Turk, Zdenka ; Vucelić, Boris Inflammation is the main determinant of bone loss in naive patients with Crohn disease // Gastroenterology (New York, N.Y. 1943). 2008. str. A512-A512

Podaci o odgovornosti

Turk, Nikša ; Čuković-Čavka, Silvija ; Koršić, Mirko ; Turk, Zdenka ; Vucelić, Boris

engleski

Inflammation is the main determinant of bone loss in naive patients with Crohn disease

Background/Aim The high incidence of bone disease and increasing evidence for Crohn disease affecting bone in corticosteroid users and non-users suggest that bone metabolism is affected by inflammatory process. As the biogenesis of receptor activator of nuclear factor &#954; B-ligand (RANKL) and its decoy receptor osteoprotegerin (OPG) may be a consequence of intestinal inflammation and because this signal pathway is shared between the immune and bone system, we hypothesized that the action of sRANKL, OPG and other inflammatory cytokines is not limited to the induction of local inflammation but might be directly or indirectly involved in the activation of bone metabolism. This study aimed to determine comparative serum levels of proinflammatory cytokines, markers of bone formation and resorption, and regulatory molecules of osteoclast biogenesis, in na&iuml ; ; ve and long-standing patients with Crohn disease. Patients and Methods The study included 95 patients, 15 of them newly diagnosed and untreated. Serum sRANKL, OPG, TNF-&#945; , IL-1&#946; , IL-6, osteocalcin and C-telopeptide I were measured by immunoassay. The spine and total hip bone mineral density (BMD) was measured by DXA. Results Decreased BMD at diagnosis was found in 53% and low bone mass in 72% of the study population. The newly diagnosed, untreated patients showed correlation between TNF-&#945; and sRANKL (r=0.6 ; p=0.027), and this positive relationship characterized the study population as a whole (r=0.5 ; p=0.002). Multiple regression identified TNF-&#945; as the best predictor of sRANKL (p<0.001). Patients with increased parameter of bone resorption were characterized by elevation of TNF-&#945; , IL-6, CRP and OPG in systemic circulation. Analysis of the OPG and sRANKL relationship according to subgroups showed absence of correlation in patients with healthy skeleton, and an inverse relationship in those with pathologic BMD (r=-0.36 ; p=0.003). In newly diagnosed patients with BMD t-score&#8804; -1.0, the correlation between sRANKL and OPG was highly inverse (r=-0.8 ; p=0.02). Conclusion Bone disease that accompanies Crohn disease at diagnosis in previously untreated patients suggests that bone metabolism is affected by the underlying inflammatory process per se, as probably confirmed by our finding that the central proinflammatory cytokine TNF-&#945; was strongly associated with the osteoclastogenic mediator RANKL.

Crohn's disease; Metabolic bone disease; Proinflammatory cytokines; Receptor activator of nuclear factor &#954; B-ligand; Osteoprotegerin

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

A512-A512.

2008.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Gastroenterology (New York, N.Y. 1943)

0016-5085

Podaci o skupu

AGA Institute and Digestive Disease Week 2008

predavanje

17.05.2008-22.05.2008

San Diego (CA), Sjedinjene Američke Države

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost